secwatch.observer — SEC 8-K summary
======================================

Issuer:     ARS Pharmaceuticals, Inc. (SPRY)
CIK:        0001671858
Form:       8-K
Filed at:   2022-03-17T23:59:59+00:00
Accession:  0001193125-22-078295
Event type: leadership
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Silverback Therapeutics Director Thilo Schroeder to not stand for re-election; resigns from audit committee
--------------------------------------------------------------------------------

- Dr. Schroeder will not stand for re-election as Class II director at 2022 annual meeting.
- He also resigned from the audit committee effective March 14, 2022.
- Departure is not due to any dispute or disagreement with the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1671858/000119312522078295/0001193125-22-078295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1671858/000119312522078295/d324895d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-078295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer